OTC · Medical - Specialties

Aamaxan Transport Group, Inc. (AAXT) Stock

$0.00 OTC: AAXT Healthcare

Aamaxan Transport Group, Inc. manufactures medical products that are used during hemodialysis therapy.

Valuation

MetricValue
Price$0.00
Market Cap$1599
P/E Ratio0.00
P/B Ratio0.00
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE54.17%
ROA
ROCE-42.63%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio0.00

Annual Financials (USD)

Metric200520062007
Revenue$0$0$0
Operating Profit$0$0$0
Net Profit$0$0$0
EPS$-0.32$-0.13$0.00
Op Margin

Balance Sheet (USD)

Metric200520062007
Total Assets$0$0$0
Total Liabilities$0$0$0
Cash$0$0$0
Borrowings$0$0$0

Cash Flow (USD)

Metric200520062007
Operating Cash Flow$0$0$0
Investing Cash Flow$0$0$0
Financing Cash Flow$0$0$0
Net Cash Flow$0$0$0
Free Cash Flow$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.05
FCF Yield-1461.35%
Quick Ratio0.00
Interest Coverage0.00
Return 1Y
Return 3Y
Return 5Y

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BMGPBiomagnetics Diagnostics Corp. $0.00 0.00 $1265 0.00%
DMSIDermisonics, Inc. $0.00 0.00 $1917 0.00%
ETAOFEtao International Co., Ltd. $0.00 0.00 $512 0.00%
IBXGiBX Group, Inc. $0.00 $1975 0.00%
JUVAFJuva Life Inc. $0.00 0.00 $1641 0.00%

About Aamaxan Transport Group, Inc.

Aamaxan Transport Group, Inc. manufactures medical products that are used during hemodialysis therapy. The company was founded as Shanghai Medical Technology Co., Ltd. and changed its name to Aamaxan Transport Group, Inc. in April 2008. The company is based in Shanghai, China.

Aamaxan Transport Group, Inc. (AAXT) stock trades at $0.00 with a market capitalization of $1599. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Aamaxan Transport Group, Inc. generates a return on equity (ROE) of 54.17% — well above the market average, a sign of a high-quality business, return on capital employed of -42.63%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.amax-tech.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides